Autologous cell therapy is a modern medical method that makes use of the body's natural regenerative processes. It is based on taking the patient's blood and preparing substances from it, such as platelet-rich plasma (PRP) or fibrin, which contain growth factors and cells that promote tissue regeneration. This process is carried out using advanced technology, such as Arthrex systems, which enable the precise separation of individual blood components.

Platelet-rich plasma is particularly valued in autologous therapy due to its high platelet content, which supports natural repair processes in the body. Fibrin, on the other hand, acts as a matrix to promote cell migration and activity. This therapy is used in many medical fields, including orthopaedics, dermatology and aesthetic medicine, where it supports tissue reconstruction.

By using the body's own resources, autologous cell therapy minimises the risk of allergic reactions and is a safe alternative to other regenerative methods.